ArticleFrontiers in oncology2022

Effects of Stereotactic Body Radiation Therapy Plus PD-1 Inhibitors for Patients With Transarterial Chemoembolization Refractory.

Yan-Jun Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.